Principal Investigator
Ayham Alkhachroum
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20230056
Clinical Trial Summary
NN111: A PHASE-2B, DOUBLE-BLIND, RANDOMIZED CONTROLLED TRIAL TO EVALUATE THE ACTIVITY AND SAFETY OF INEBILIZUMAB IN ANTI-NMDA RECEPTOR ENCEPHALITIS AND ASSESS MARKERS OF DISEASE
Phase
TBD
Funding Agency/Sponsor
Other
Disease
Other
Contact Information
Study Contact
Julie Steele
Phone Number
+1 (305) 7759502
Email
j.steele@miami.edu